Fifty Years of Diazeniumdiolate Research. From Laboratory Curiosity to Broad-Spectrum Biomedical Advances
Open Access
- 30 September 2011
- journal article
- review article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 6 (11) , 1147-1155
Abstract
Here I show that a “pure” research project, seemingly totally lacking in practical application when it was first published, can years later spark a whole new scientific field with the potential to revolutionize clinical practice. A 1961 publication describing adducts of nitric oxide (NO) with certain nucleophiles attracted little notice at the time, but later work showing that the adducts could be hydrolyzed to regenerate the NO in bioactive form has provided the foundation for a host of biomedical applications. Crucial to the discovery of widely used tools for studying NO’s chemical biology as well as for the design of a variety of promising therapeutic advances has been the increasingly detailed understanding of the physicochemical properties of these “diazeniumdiolates” (also known as NONOates).Keywords
Funding Information
- National Cancer Institute
- National Institutes of Health
This publication has 65 references indexed in Scilit:
- HNO and NO Release from a Primary Amine-Based Diazeniumdiolate As a Function of pHInorganic Chemistry, 2011
- The Nitric Oxide Prodrug JS-K Is Effective against Non–Small-Cell Lung Cancer Cells In Vitro and In Vivo: Involvement of Reactive Oxygen SpeciesThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Dual Mechanisms of HNO Generation by a Nitroxyl Prodrug of the Diazeniumdiolate (NONOate) ClassJournal of the American Chemical Society, 2010
- “Click” Reaction in Conjunction with Diazeniumdiolate Chemistry: Developing High-Load Nitric Oxide DonorsOrganic Letters, 2010
- Mechanistic Studies on the Reaction between R2N‐NONOates and Aquacobalamin: Evidence for Direct Transfer of a Nitroxyl Group from R2N‐NONOates to Cobalt(III) CentersAngewandte Chemie International Edition, 2009
- Hydrolytic Reactivity Trends among Potential Prodrugs of the O2-Glycosylated Diazeniumdiolate Family. Targeting Nitric Oxide to Macrophages for Antileishmanial ActivityJournal of Medicinal Chemistry, 2008
- Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasiaFree Radical Biology and Medicine, 2008
- JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cellsBlood, 2007
- Preparation and Reactivity of O2-Sulfonated DiazeniumdiolatesThe Journal of Organic Chemistry, 2002
- Nitric oxide: A cytotoxic activated macrophage effector moleculeBiochemical and Biophysical Research Communications, 1988